Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Learn which credit cards can help you maximize travel points. Optimize your travel rewards strategy effectively.
24,332 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
When a beloved soap star hints at a fragile return, it isn’t just headlines that shake. It can ripple into budgets, i...
A mid-June rally lifted AMC Entertainment after it completed a $150 million equity offering. The move boosted sentime...
The FDA confirms a national shortage of needles used detect breast after a recall. Hospitals warn the gap could delay...
Roblox faces a tough year in the market, but a rebound isn’t off the table. This guide breaks down the business, risk...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Gold prices hovering near $4,000 can prompt questions about safety, liquidity, and potential gains. This guide helps ...
Famed investor Michael Burry reportedly tacks a bearish stance onto Micron Technology, signaling renewed caution for ...
SpaceX’s rapid move into index funds signals a shift in how private tech breakthroughs reach everyday investors. This...
Investors are eyeing yuanbao (yb) 2026 earnings as the company pivots toward new revenue streams. This guide breaks d...
Two AI-focused names have pulled back recently, but their paths diverge. This guide breaks down why palantir sandisk ...
In 2026, Palantir and Sandisk both delivered blowout earnings, but their stock moves told different stories. This art...